Data Visualization Part 4: Telling a story

Complex findings require many moving pieces to be held in the mind at once to grasp the full picture. In our DPS® studies, for instance, RG+A determines not only what will happen, but also where, when, and why. Answering these questions provides a comprehensive view of the overall market space and the decisions physicians make that create the prescribing environment.

Read More

Managing uncertainty and probability in BD&L Marketing Research

Healthcare products companies of all sizes flourish or fade based on their ability to build robust portfolios by acquiring high-value assets and culling low-level ones. In 2015, there were 468 announced deals involving therapeutic drug assets, devices, diagnostics and insurance companies, according to data from Thomson Reuters, representing a 10% increase over 2014 and a 90% increase over 2012. This extends a trend of an increasing number of deals, beginning in 2013 after a sustained decrease during the economic downturn around 2008.

Read More

Contracting Beyond Rebates and Discounts

As provider reimbursement systems move toward compensation for success rather than service, some health plans are encouraging manufacturers to take on some of the market risks for new agents in exchange for preferential management. As pharmaceutical companies seek to develop new and successful market access strategies, they should proactively approach certain types of plans with offers of performance-based contracts.

Read More

It Took Twenty Years to Become an Overnight Sensation

At a Spring PMRG meeting, the highest rated presentation, given before a standing-room-only audience, debuted a new mode of marketing research called patient simulation. The presentation focused on how this method provided more reliable data than traditional allocation and estimation methods and improved response and interview completion rates dramatically. If you were at PMRG CONNECT 2016 […]

Read More

Can Patient Chart Pulls Help Predict Physician Behavior?

Welcome back to my three-part series on physician treatment behavior. If you missed the first installment, you can find it here. In this second installment, I will be discussing the use of patient chart pulls as a way to understand both current and future physician prescribing. Patient chart pulls offer significant advantages to allocation studies, […]

Read More

Estimating physician treatment behavior with allocation – we can do better!

This is the first installment of a three-part series where I will be exploring methods of estimating physician treatment behavior. I’ll be looking at three common approaches used in healthcare market research: patient allocations, patient chart pulls, and patient simulation studies – and exploring the trade-offs associated with each. Predicting how physicians will act in […]

Read More